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Effect of a streptococcal preparation (OK432) on natural
killer activity of tumour-associated lymphoid cells in human
ovarian carcinoma and on lysis of fresh ovarian tumour cells
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A. Mantovani
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Ginecologia, Universita di Milano, Ospedale S. Gerardo, Monza (Milan), Italy
Summary The streptococcal preparation OK432 was studied for its effects on natural killer (NK) activity of
peripheral blood lymphocytes (PBL) from normal donors and from ovarian cancer patients, and of tumour-
associated lymphocytes (TAL) from peritoneal effusions. OK432 augmented NK activity against the
susceptible K562 line and induced killing of the relatively resistant Raji line. Freshly isolated ovarian
carcinoma cells were relatively resistant to killing by unstimulated PBL and TAL. OK432 induced significant,
though low, levels of cytotoxicity against 5'Cr-labelled ovarian carcinoma cells. Augmentation of killing of
fresh tumour cells by OK432 was best observed in a 20h assay and both autologous and allogeneic targets
were lysed. PBL were separated on discontinuous Percoll gradients. Unstimulated and OK432-boosted activity
were enriched in the lower density fractions where large granular lymphocytes (LGL) and activity against
K562 were found. Thus, OK432 augments NK activity of PBL and TAL in human ovarian carcinomas and
induces low, but significant, levels of killing of fresh tumour cells. Effector cells involved in killing of fresh
ovarian tumours copurify with LGL on discontinuous gradients ofPercoll.
Natural killer (NK) cells are defined on the basis of
their ability to cause rapid lysis of susceptible target
cell lines in the absence of overt sensitization
(Cudkowicz et al., 1978; Herberman & Holden,
1978; Herberman & Ortaldo, 1981; Herberman,
1982). A role for NK cells has been suggested in
surveillance against neoplasia and in the regulation
of growth of established tumours and metastasis
(Cudkowicz et al., 1978; Cudkowicz & Hockman,
1979; Herberman & Ortaldo, 1981). The regulation
of NK activity is complex and various agents have
been shown to stimulate natural cytotoxicity
(Cudkowicz et al., 1978; Cudkowicz & Hockman,
1979; Herberman & Holden, 1978; Herberman &
Ortaldo, 1981; Herberman, 1982). OK432 is a
streptococcal preparation with immunomodulatory
activity (Uchida & Hoshino, 1980a, b). OK432 has
been shown to augment NK activity in vivo or in
vitro, in rodents and humans (Oshimi et al., 1980;
Uchida & Micksche, 1981,a, b). IFN and
interleukin 2 (IL2) may be involved in the
activation of NK cells by OK432 (Wakasugi et al.,
1982). Unlike cell lines, fresh tumour cells are
usually relatively resistant to natural cytotoxicity by
unstimulated effector cells (Moore et al., 1982;
Pattengale et al., 1982; Serrate et al., 1982; Vanky
et al., 1980; Verkmeister et al., 1979; Vose et al.,
1977a, b; 1978; Vose & Moore, 1980; Zarling et al.,
1979). Vanky et al., (1980) showed that in various
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human tumours IFN could induce or augment
cytotoxicity against fresh neoplastic cells provided
allogeneic combinations of effectors and targets
were studied. As found for other human tumours,
freshly isolated ovarian carcinoma cells were
relatively resistant to NK activity (Allavena et al.,
1982; Mantovani et al., 1980). In vitro exposure of
effector cells (both allogeneic and autologous) to
IFN caused modest enhancement of lysis using
lymphoid cells isolated from peripheral blood and
ascites tumour (Allavena et al., 1982; Mantovani et
al., 1980).
The capacity of OK432 to stimulate NK activity
prompted us to investigate the effect of this agent
on natural cytotoxicity in human ovarian
carcinoma, a tumour previously studied for this
parameter in some detail (Allavena et al., 1982;
Introna et al., 1983; Mantovani et al., 1980; 1981).
Results indicate that OK432 augments NK activity
of peripheral blood (PBL) and tumour-associated
lymphoid cells (TAL) in this human neoplasm.
Moreover, following exposure of PBL or TAL to
OK432, appreciable levels of lysis of fresh ovarian
carcinoma cells were observed with both autologous
or allogeneic effectors.
Materials and methods
Human subjects
Eleven patients with histologically confirmed ascites
ovarian epithelial tumours admitted to the
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Department of Oncology, Clinica Ostetrica e
Ginecologica, Universita di Milano, Ospedale S.
Gerardo, Monza (Milan), formed the case list for
this study (Table I). All patients had cancers
classified as stages III and IV. In addition, in one
criss-cross experiment, a patient with lymphoma
was used (Patient no. 2, Table III). The presence of
tumour cells in ascitic fluids was independently
checked by pathologists. The control population
consisted of 40 normal healthy adult volunteers.
Heparinized venous blood (10-50ml) was obtained
by venipuncture, and carcinomatous ascites were
collected by paracentesis or at laparotomy. Solid
tumour specimens were obtained during surgery.
PBL
Blood was diluted 1:5 with PBS (Eurobio, Paris),
and 40ml was then placed on 10ml Ficoll-Hypaque
(Eurobio) for centrifugation at 400g for 20min at
room temperature. Mononuclear cells were
collected at the interface and washed with PBS, and
10-30 x 106 cells were incubated in 10-20ml of
RPMI-1640 medium supplemented with 20% FBS
(Gibco-Biocult, Glasgow, Scotland) for 45min at
37°C in plastic petri dishes (#3003; Falcon Plastics,
Oxnard, Calif.). Nonadherent cells were collected,
centrifuged at 400 g for 5min, and finally
resuspended in RPMI-1640 medium with 10% FBS
and 50 pg gentamycinml- . Nonadherent cell
preparations were only partially depleted of
monocytes inasmuch as 2-4% of these cells as
compared to 10-30% of the original mononuclear
cell suspensions (Mantovani et al., 1980) were
mononuclear phagocytes as assessed by
morphology, avid uptake of neutral red, and
staining for nonspecific esterase.
TAL and ovarian carcinoma cells
Enriched preparations of ovarian tumor cells and
TAL were obtained by stepwise application of
density and velocity sedimentation on
discontinuous Ficoll-Hypaque gradient (Mantovani
et al., 1980).
Briefly, Ficoll-Hypaque separated ascites
mononuclear cells, deprived of macrophages by
adherence, were fractionated on discontinuous
Ficoll-Hypaque (10ml 75%, 15ml 100% gradient).
Tumour cells sedimented on top of the 75%
fraction and lymphoid cells were found at the 75-
100% interface. Only preparations of >95% purity
assessed morphologically were used.
For the isolation of ovarian cells and tumour-
associated lymphocytes from solid tumours,
specimens were minced mechanically and then
exposed for 45min at 37°C to 0.3% collagenase
(#40130; Sigma Chemical Co., St. Louis, Mo., 02
Worthington Biomedical Corp., Freehold, N.J.) in
BME (Eurobio) containing 10pg DNaseml-1.
After 2 washes with 50ml BME, disaggregated cells
were then treated as described above for the
cellular preparations isolated from the ascitic fluids.
IFN
Partially purified human fibroblast IFN was
obtained from Serono (Frone, Serono, Rome Italy).
Lymphoidcells(1-5 x 106ml 1) wereculturedfor20h
in the presence of I03UIFNml1 in growth medium.
Control lymphocytes were cultured alone. Lymphoid
cellswerewashedwith50mlPBSbeforetheircytotoxic
capacity was tested.
OK432
OK432, a lyophilized preparation of attenuated
strain Su of Streptococcus haemoliticus (Group A,
Type 3), was obtained from Chugai Pharmaceutical
Co. Ltd., Tokyo, Japan. Effector cells at a
concentration of 1-2 x 106mI-P in RPMI 1640 10%
FBS (Gibco) were cultured for 20h with OK432
(usually 0.5KEmlP, 1 KE=0.1 mg dried
streptococci) in humidified atmosphere of 5%
CO2 in air at 37°C. Lyophilized powder was
reconstituted in PBS. Control lymphocytes were
cultured alone. After incubation lymphoid cells
were washed 2-3 times and resuspended in
complete medium.
Target cells
NK activity of PBL was measured against the
highly sensitive K562 (Allavena et al., 1981) and
relatively resistant Raji cell lines (Pulvertaft, 1965).
Target cells were pre-incubated with 20-50pCi
51Cr (Radiochemical Centre, Amersham,
Buckinghamshire, England) at 37°C fpr 45min.
Fresh ovarian carcinoma cells (1-5 x 106 in 0.2-
1ml growth medium) were labelled by incubation
for 20h at 37°C (overnight) with 20-50pCi 51Cr
(Kedar et al., 1981).
Labelled cells were washed twice with 50ml of
PBS before use in cytolysis assays.
Cytotoxicity assay
51Cr labelled tumour cells (104) were cultured in
0.1 ml RPMI 1640 medium with 10% serum in
round-bottomed wells of Microtest plates (Sterilin
Ltd., Teddington, Middlesex, England). The
routinely employed attacker:target (A:T) ratios
were 25:1 and 50:1 for ovarian carcinoma cells.
Lysis of K562 and Raji was routinely measured at
A:T ranging from 6:1 to 50:1, but only data for
25:1 (K562) and 50:1 (Raji) are presented. Isotope
release was determined after 4 and 20h of
incubation, except for occasional experiments in
which cytotoxicity was measured only at 4h.EFFECT OF OK432 ON TUMOUR-ASSOCIATED NK CELLS 517
Isotope release was calculated as (A/B) x 100, were
A is the isotope in the supernatant and B is the
total incorporated radioactivity released by
incubation with 1% sodium dodecyl sulfate in
water. Specific lysis was calculated by substraction
of the spontaneous isotope release of tumour cells
alone. Spontaneous 51Cr release from ovarian
carcinoma cells ranged from 8.6 to 30.6% after 4h
incubation and from 21.6 to 37.4% after 20h
(Table I). In 4 experiments, control cultures to
which unlabelled ovarian carcinoma cells were
added instead of lymphocytes, were included;
isotope release was not different from that of
labelled target cells alone.
Percollfractionation ofperipheral blood lymphocytes
Lymphoid cells were separated on Percoll as
described in detail elsewhere (Introna et al., 1983;
Timonen & Saksela, 1980; Timonen et al., 1981).
Briefly, discontinuous gradients of Percoll (7 steps)
from 42.5% to 55% (v/v) were prepared with
RPMI 1640 medium with 10% FBS, after adjusting
the osmolarity to 285mosmol. Cells were deprived
of monocytes by adherence on plastic, carbonyl iron
and nylon wool columns and kept at 4°C overnight
before fractionation at 550g for 30min.
Enrichment in large granular lymphocytes (LGL)
was evaluated on May-Grunwald-Giemsa stained
cytocentrifuge smears (Introna et al., 1983;
Timonen & Saksela, 1980; Timonen et al., 1981).
Statistical analysis
At least 3 replicates per experimental group were
employed throughout, and results of cytotoxicity
tests were calculated as mean+s.d.; 4-6% increases
in isotope release above base line were usually
statistically significant at P<0.05 (Duncan's new
multiple-range test). The incidence of stimulation
was analysed by Fisher's exact test.
Results
A first series of experiments was designed to define
the conditions for optimal augmentation of normal
PBL NK activity against cell lines (K562 and Raji)
by OK432. Fibroblast IFN was used as a standard
immunostimulatory agent. In agreement with
previous reports OK432 augmented lysis of the NK
susceptible K562 target (Figure 1) and induced
killing of the relatively resistant Raji line (Figure 2).
Optimal stimulation was observed at OK432
concentrations of 0.1-0.5KEml-1 and after
incubation times of 20h (data not shown).
Therefore in subsequent experiments effector cells
were exposed to 0.5KEml-' for 20h. Previous
studies have shown that TAL from ascites and, to
an even greater extent, solid ovarian tumours have
(Allavena et al., 1981) usually low NK activity
compared to PBL effectors (Allavena et al., 1982).
It was therefore of interest to elucidate whether
OK432 stimulated NK activity (vs. K562) of TAL
and, by way of comparison, of PBL from ovarian
cancer patients. As shown by the representative
experiment in Table II, OK432 was effective at
stimulating NK activity of PBL and TAL and,
Table H Effect of OK432 on NK activity vs K562 of
PBL and TAL from ovarian carcinoma patients
% specific lysis (± s.d.) with
Effector cells"b medium IFN OK432
Normal PBL 34.3 +4.0 41.2+2.9 47.4+ 1.1
Patient's PBL (no. 8) 18.9+0.2 25.6+0.1 33.5+4.0
Patient's TAL (no. 8) 6.5+0.8 NT 54.7+ 1.2
'Effector cells were incubated for 20h with IFN-,B (103
unitsml-P') or OK432 (0.5KEml ).
bA:T=50:1.
NT: not tested.
Table I Characteristics of ovarian carcinoma cells used as targets in cytolysis assays
Spontaneous release (%)
Patient ,
no. Thmour Histology Grade Stage 4h 20h
1 Solid undifferentiated 3 III 12.6 36.2
3 Ascites serous 3 III 13.8 21.6
4 Ascites undifferentiated 2 IV 9.9 32.3
5 Solid serous 2 IV 15.4 33.3
6 Ascites serous 3 III 13.5 34.5
7 Ascites serous 1 IV 8.6 33.8
8 Ascites serous 1 IV 11.3 36.6
9 Ascites undifferentiated 4 III 10.5 29.9
10 Ascites serous 3 III 30.6 37.4
11 Ascites serous 2 III 18.3 NT
12 Ascites serous 1 IV 12.2 NT
NT: not tested.518 F. COLOTTA et al.
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Figure 1 Effect of OK-432 on NK activity vs K562 cells. Panel a shows boosting of activity by OK-432
(0.5KEml-1 for 20h) and by IFN (103 Units ml-' for 20h) tested at different A:T ratios. Panels b and c
show a typical dose-response experiment (A:T=25:1) using OK432 (panel B) and IFN (C). Specific lysis+s.d.
when IFN was tested in parallel, levels of boosting
were somewhat higher with OK432 than those with
IFN. Similar results were obtained in 5 additional
patients tested for boosting of NK activity (vs.
K562) by OK432. We then examined the capacity
of OK432 to stimulate killing of fresh ovarian
carcinoma cells, using PBL from normal donors as
effectors or PBL and TAL from cancer patients in
autologous or allogeneic combinations. In
agreement with previous results in a larger series of
subjects, (Allavena et al., 1981; Mantovani et al.,
1980), PBL and TAL from ovarian cancer patients
showed little or no cytotoxicity against autologous
or allogeneic carcinoma, with levels of activity
(usually < 10% specific lysis at 4h and <15% at
20h), when present, not exceeding those
occasionally encountered with normal PBL (Figure
3). Table III presents data on the effect of OK432,
and by way of comparison IFN, on killing of fresh
ovarian carcinoma cells. Only in a minority of the
experiments did we have available lymphoid and
tumour cells from 2 different patients on the same
day so as to run criss-cross combinations of
effectors and target cells: these experiments are also
shown in detail in Table III, while Table IV
presents all experiments performed and Table V
sets out a synopsis of overall effect of OK432 on
killing of fresh ovarian carcinoma cells. OK432 was
able to augment cytotoxicity against fresh ovarian
tumours with all effector populations tested
(normal PBL, ovarian cancer PBL and TAL).
OK432-induced cytotoxicity was best observed
when a 20h assay was performed. Boosting of
cytotoxicity was rarely observed, particularly with
PBL and TAL from ovarian cancer patients in a 4h
assay (only in 2/8 cases with PBL and 1/9 with
TAL) with low levels of stimulation (absolute
increases in lysis, 11.0% and 9.6% for PBL and
7.2% for TAL). Augmentation of killing of fresh
ovarian tumours was best evident in a 20h 5"Cr
release assay, both in terms of the frequency of
positive responses (for instance for TAL 5/7 at 20h
compared to 1/9 at 4h) and in terms of absolute
levels of specific lysis attained (Table IV). OK432
augmented the cytotoxic activity of PBL and TAL
against both autologous and allogeneic target cells.
For instance in the experiments shown in Table III
OK432-stimulated TAL from Patients No. 4 caused
13.3+ 1.7% lysis of autologous and 7.4+0.2% lysis
of allogeneic carcinoma cells with absolute increases
in cytotoxicity of 10.4 and 7.5% respectively
(P<0.01). In one experiment OK432-boosted
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Figure 2 Effect of OK432 on natural cytotoxicity against Raji cells. Panel a (4h assay) and b (20h assay)
show boosting of activity by OK432 (0.5KEml-1, 20h preincubation) and by IFN (103 Units ml-', 20h
preincubation) tested at different A:T ratios. Panels c and d (4h and 20h assay, OK432), e and f (4h and
20h assay, IFN) show typical dose-response experiments (A:T= 50:1). Specific lysis +s.d.
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Figure 3 Cytotoxicity of PBL and TAL against autologous and allogeneic freshly isolated carcinoma cells.
Cytolysis was measured in a 4h (0) and a 20h (-) assay, with the use of an A:T=50:1.
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Ovarian % specific lysis with medium/with IFN/with OK-432
tumour no. Effector cells' 4h 20h
1 Normal PBL
Autologous PBL
TAL
Patient no. 2 TAL
3 Normal PBL
Autologous PBL
TAL
Patient no. 4 TAL
4 Normal PBL
Autologous PBL
TAL
Patient no. 3 TAL
5 Normal PBL
Patient no. 6 TAL
6 Normal PBL
Autologous TAL
7 Normal PBL
Autologous PBL
TAL
8 Normal PBL
Autologous PBL
9 Normal PBL
Autologous PBL
TAL
10 Normal PBL
Autologous PBL
TAL
11 Normal PBL
Autologous PBL
TAL
12 Autologous TAL
1.4/1.6/1.0
2.5/1.6/1.7
0.8/1.5/2.8
1.9/2.2/1.0
0.2/4.2/3.6
1.6/2.2/2.4
2.6/3.0/2.2
0.5/2.5/2.6
15.8/34.0/31.4c
7.6/18.8c/17.2c
1.8/5.2/4.4
5.4/21.2c/22.0c
0.7/9.5c/12.4c
0.7/2.8/12.8cc
-3.6/4.2b/6.2b
1.3/1.6/4.7
1.3/NT/2.3
0/NT/0
-0.1/NT/0.3
- 1.7/NT/0.5
0.7/NT/- 1.4
0.8/1.7/10.1c
0.9/0.2/4.3
0.6/NT/7.8b
4.1/15.4c/23.9c, d
0.2/4.5/11.2c-d
-1.3/-1.3/-0.4
- 1.2/NT/0.1
-0.7/NT/0.3
- 1.6/NT/0.8
8/NT/10.9
4.3/6.6/10.6b
4.7/5.8/5.0
1.8/8.9c/14.Oc,d
3.0/2.7/6.0
1.1/5.0/13.4c d
2.5/4.4/9.6b.d
1.7/4.0/5.0
-0.1/1.2/7.4
b
24.4/29.4 /31.2b
15.4/19.3/26.7b e
2.9/4.1/13.3cc
9.9/23.7c/25.Oc
6.6/21.1l/29.9c,d
5.3/10.3b/27.6', e
-2.1/7.2 /9.8-
- 1.8/- 1.0/9.3cc
6.2/NT/14.2c
-2.7/NT/5.8b
-6.4/NT/5.6b
- 6.6/NT/8.5c
- 10.1/NT/4.lc
2.4/5.6/32.7ce
3.2/0.9/23.8c
4.3/NT/28.4c
8.9/25.2c/27.9c
-0.1/5.4d/22.8c e
-2.9/0.3/2.3
NT
NT
NT
NT
'A:T=50:1.
bp<0.05 vs unstimulated cells.
CP<0.01 vs unstimulated cells.
dp<0.005 vs IFN-boosted cells.
'P<0.01 vs IFN-boosted cells.
NT=not tested.
Table V Augmentation of lysis offresh ovarian carcinoma cells by OK-432: Summary of overall results.
Incubation No. tumour cells with enhanced Absolute increase in lysis
time lysis/total tested (% median with range)
Effector cells (h) with IFN with OK-432 with IFN with OK-432
Normal PBL 4 5/7 5/10 8.8(4.0-18.2) 11.7(9.3-19.8)
20 4/7 9/98 11.9(5.0-16.3) 13.7(6.3-30.3)
Patient PBL 4 2/5 2/8 4.3; 11.2 9.6; 11.0
(autologous) 20 1/5 6/78 5.5 12.7(7.1-22.9)
Patient TAL 4 0/5 1/9 7.2
(autologous) 20 1/5 5/78 7.1 12.2(10.4-24.1)
Patient TAL 4 1/4 1/4 15.8 16.6
(allogeneic) 20 3/4 3/4 5.6(5.0-18.8) 18.0(7.5-22.3)
'p<0.05 (Fischer's exact test) vs IFN-boosted cells.
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effector cells were tested for cytotoxicity against
5tCr-labelled autologous or allogeneic lymphocytes
and found to be inactive (data not shown).
In this series of experiments, IFN-,B was used as
a reference compound, since the effect of this agent
on cytotoxicity in ovarian carcinoma has been
previously investigated. In confirmation of previous
data, IFN induced or augmented killing of part of
the fresh ovarian carcinoma cell preparations by
normal PBL, ovarian cancer PBL and TAL. The
effect of IFN was best observed in a 20h assay and
IFN-boosted cytotoxicity was expressed against
both autologous and allogeneic carcinoma cells. In
most of the experiments in which IFN and OK432
were tested in parallel (Tables III and IV), OK432
resulted in significantly higher cytotoxicity levels
than did IFN. Moreover, OK432 treatment resulted
in a significantly higher frequency of stimulation
than IFN (Table V). For instance, using TAL as
effectors, OK432 resulted in significant stimulation
of lysis in 5/7 autologous combinations tested
whereas this occurred in only 1/5 experiments with
IFN (P<0.05). Effector cells involved in NK
activity against cell lines (K562) have been
identified as LGL (Saksela et al., 1979; Timonen et
al., 1979a,b). It was of interest to determine
whether effector cells involved in killing of fresh
ovarian carcinoma cells were indeed LGL. Blood
LGL sedimented in low density Percoll fractions
with an enrichment of 4-7 times compared with
unfractioned PBL: in the experiment presented in
Table VI the % LGL in fraction 2 was 70.3%
compared to 11.3% of the input population and
0.6% of fraction 7. The distribution of NK activity
against K562 closely followed that of LGL (Figure
4). Interestingly, basal and OK432-boosted
Table VI Enrichment of LGL by discontinuous Percoll gradients.
Total number Distribution
Fraction ofcells ofrecovered Lymphoid cells Contaiminating
no. (x 10-6) cells (%) LGL(%) Other (%) monocytes (%)
Input 50 11.3 86.6 2.1
1 1.5 3 14.4 32.4 53.2
2 3.5 7 70.3 28.7 1.0
3 6 14 41.2 58.8
4 10 20 10.6 89.4
5 15 30 2.2 97.8
6 8 16 0.8 99.2
7 5 10 0.6 99.4
a b
Input 1 2 3 4 5 6 7
c
201
Input 1 2 3 4 5 6 7
Fractions of density gradient
Figure 4 Cytotoxic activity against K562 and ovarian carcinoma cells exerted by fractions of density
gradient. Cytotoxicity against K562 (panel a, 4h assay, A:T=50:1) and freshly isolated ovarian carcinoma
cells (panel b, 4h assay and panel c, 20h assay, A:T=50:1) by unstimulated, IFN-boosted (103 units ml- 1,
20h preincubation) and OK432-stimulated (0.5KEml-', 20h preincubation) fractions of discontinuous
density gradient separation. Specific lysis+s.d.
CO
._4
0
;r, ._
CFsEFFECT OF OK432 ON TUMOUR-ASSOCIATED NK CELLS 523
activities against fresh ovarian carcinoma no. 8
closely followed the sedimentation profile of LGL
and anti K562 activity (Figure 4).
Discussion
Previous reports have shown that the streptococcal
preparation OK432 is an effective stimulator of NK
activity in human (Uchida & Micksche, 1981a,b).
The mechanism of action is, however, a matter of
controversy. It has been suggested that induction of
IFN is not involved in augmentation of NK
activity by this agent (Uchida & Micksche, 1982),
but Wakasugi et al. (1982) recently reported that
IFN and IL-2 mediate the effect of OK432 on NK
cells. In the present report we examined the effect
of OK432 on NK activity (vs. K562) of TAL from
ascites ovarian carcinoma, which were previously
shown to have impaired natural cytotoxicity
(Allavena et al., 1981; Mantovani et al., 1980).
OK432 significantly augmented the NK activity of
TAL. It remains to be elucidated whether OK432
augmented NK activity of TAL by acting on the
low numbers of LGL usually found at this site
(Introna et al., 1983) or by recruiting different
effectors. A similar effect was reported on lymphoid
cells from pleural effusions and it was suggested
that inhibition of suppressor cells played some role
in the stimulatory activity of OK432 (Uchida &
Micksche, 1982).
Although suppressor mechanisms can be
demonstrated in the ascites of some ovarian cancer
patients (Allavena et al., 1981; Introna et al., 1982)
evidence has suggested that defective NK activity of
TAL was mainly related to a low frequency of
LGL (Introna et al., 1983; Introna & Mantovani,
1983) unlike pleural effusions where high numbers
of LGL were reported (Uchida & Micksche,
1981a). Hence it appears unlikely that interference
with suppressor mechanisms plays a major role in
boosting of NK activity of TAL from ascites
ovarian tumours.
Fresh tumour cells from human neoplastic tissues
are generally resistant to natural cytotoxicity as
measured by conventional cytolysis assays
(Pattengale et al., 1982; Serrate et al., 1982; Vanky
et al., 1980; Verkmeister et al., 1979; Vose et al.,
1977a, 1977b, 1978; Vose & Moore, 1980; Zarling
et al., 1979). In a study with various human
tumours, mainly of mesenchymal origin, Vanky et
al. reported that IFN-induced killing of fresh
biopsy cells only if allogeneic combinations of PBL
and target cells were used (Vanky et al., 1980).
Killing of fresh leukaemic targets by normal
allogeneic effectors was reported by Moore et al.
(1982). Results with ovarian tumours were to some
extent different. In the absence of stimulation PBL
and TAL from ovarian cancer patients showed no
evidence of appreciable cytotoxicity against
autologous targets (Allavena et al., 1982 and Figure
3), whereas -30% of subjects with other human
tumours have PBL cytotoxic against autologous
neoplastic cells (Vose et al., 1977a, 1978; Zarling et
al., 1979). However when lung cancer was
considered by histological subtype, evidence for
autologous recognition was confined to squamous
cell carcinoma and to adenocarcinoma (Vose et al.,
1978). Our previous findings with ovarian
carcinoma (Allavena et al., 1982) were confirmed in
the limited series of subjects considered in the
present study. In vitro exposure to OK432 and, to a
lesser extent, IFN induced significant levels of lysis
of ovarian carcinoma cells, thus extending previous
observations with IFN (Allavena et al., 1982).
Stimulation of lysis by OK432 was best observed in
a 20h assay with normal PBL, ovarian cancer PBL
and TAL. Why OK432 induced lysis of fresh
tumour cells was best observed in a 20h assay
remains to be clarified. A possible explanation for
this finding is that OK432 augments the maximal
recycling capacity of effector cells, a possibility
which is currently being tested. When ovarian
cancer PBL and TAL are considered, OK432
augmented lysis against both autologous and
allogenic fresh carcinoma cells, thus extending
previous findings with IFN (Allavena et al., 1982).
Uchida & Micksche (submitted for publication)
recently made similar observations with lung
carcinoma cells as targets and these authors as well
as Serrate et al. (1982) found that low density
fractions from Percoll gradients had activity against
autologous and allogeneic tumour biopsy cells.
The effector cells involved in OK432-induced
killing of fresh ovarian carcinoma cells were not
definitively identified in the present study.
Monocyte cytotoxicity is not affected by OK432
(Rossi et al., unpublished data), and stimulation of
natural cytotoxicity was observed with cell
preparations depleted of monocytes by adherence
on plastic followed by passage through nylon wool.
Upon fractionation on discontinuous Percoll
gradients both basal and OK432-stimulated killing
of fresh ovarian carcinomas were augmented in the
low density fractions, where LGL and anti-K562
activity were recovered. These results tentatively
suggest that LGL may be involved in cytotoxicity
against fresh ovarian carcinoma cells, but the
effector cells involved in this reactivity require more
definitive characterization.
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